Arcus Biosciences, Inc. · NYSE:RCUS
Azoy Alexander sold 2,827 Arcus Biosciences, Inc. shares (Form 4)
Traded Aug 21, 2026 · Filed Aug 24, 2026
On Aug 21, 2026, Azoy Alexander (Chief Accounting Officer) sold 2,827 Arcus Biosciences, Inc. shares at US$30.00 for US$84,810 under a trading plan, leaving 39,581 shares. Filed Aug 24, 2026 (Form 4).
- Sold
- 2,827 shares
- Price
- US$30.00
- Value
- US$84,810
- Holding after
- 39,581 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Common Stock | Option exercise | 2,827 | US$15.44 | 42,408 | Direct |
| Aug 21, 2026 | Common Stock | Sale | 2,827 | US$30.00 | 39,581 | Direct |
Source
Related
- Arcus Biosciences, Inc.
- Azoy Alexander
- Arcus Biosciences, Inc. shareholders
- Form 4 · Azoy Alexander · Jun 1, 2026
- Schedule 13D/A · Gilead Sciences, Inc. · Aug 7, 2026
- Form 4 · Jaen Juan C. · Jul 13, 2026
- Form 4 · Jaen Juan C. · Jun 24, 2026
- Form 4 · Lambert Nicole · Jun 12, 2026
- Form 4 · Machado Patrick · Jun 12, 2026